Novartis’ Lucentis® received EU approval in new indication – Lucentis the only treatment available for a wide range of CNV conditions

December 8, 2016 Scipreneur Private Limited 0

Novartis’ Lucentis® received EU approval in new indication – Lucentis the only treatment available for a wide range of CNV conditions   Results of the pivotal MINERVA[5] study showed a significant gain in visual acuity of approximately 10 letters at two months, which was maintained for one year[1]   Lucentis [..]

Agitating the aluminum pot

December 8, 2016 Scipreneur Private Limited 0

Agitating the aluminum pot Denis Paiste | Materials Processing Center December 8, 2016 Industrial aluminum slabs are typically produced by blending small amounts of copper or manganese in a reservoir of molten aluminum that is rapidly cooled, a process known as direct-chill casting. Variations in the way these elements solidify [..]

Printable electronics

December 7, 2016 Scipreneur Private Limited 0

Printable electronics Jennifer Chu | MIT News Office  December 8, 2016 The next time you place your coffee order, imagine slapping onto your to-go cup a sticker that acts as an electronic decal, letting you know the precise temperature of your triple-venti no-foam latte. Someday, the high-tech stamping that produces [..]

Novartis announces Zykadia® first-line study results showing 16.6 month progression-free survival in patients with ALK+ advanced NSCLC

December 7, 2016 Scipreneur Private Limited 0

Novartis announces Zykadia® first-line study results showing 16.6 month progression-free survival in patients with ALK+ advanced NSCLC Patients without brain metastases at diagnosis experienced median progression-free survival of 26.3 months, the longest seen in a global Phase III study in ALK+ NSCLC[1]   Patients with measurable brain metastases in the [..]

FDA Approves Genentech’s Avastin® (Bevacizumab) Plus Chemotherapy for a Specific Type of Advanced Ovarian Cancer

December 7, 2016 Scipreneur Private Limited 0

FDA Approves Genentech’s Avastin® (Bevacizumab) Plus Chemotherapy for a Specific Type of Advanced Ovarian Cancer Approval based on two large Phase III studies including GOG-0213 that showed a five month overall survival difference for women with platinum-sensitive recurrent ovarian cancer on Avastin plus chemotherapy compared to chemotherapy alone In the [..]

Learning words from pictures

December 7, 2016 Scipreneur Private Limited 0

Learning words from pictures System correlates recorded speech with images, could lead to fully automated speech recognition. Larry Hardesty | MIT News Office December 7, 2016 Speech recognition systems, such as those that convert speech to text on cellphones, are generally the result of machine learning. A computer pores through [..]

Pfizer Announces Expansion of ASPIRE Awards Program for 2017 to Include $5.5M in Funding for Breast and Hematologic Cancers

December 6, 2016 Scipreneur Private Limited 0

  Pfizer Announces Expansion of ASPIRE Awards Program for 2017 to Include $5.5M in Funding for Breast and Hematologic Cancers 2016 ASPIRE Breast Cancer Research Award Winners Also Unveiled December 7, 2016  Pfizer News Pfizer Inc. (NYSE:PFE) today announced that it will expand the company’s Advancing Science through Pfizer Investigator [..]

Stanford Unveils Innovative Solar Generating Station

December 6, 2016 Scipreneur Private Limited 0

Stanford Unveils Innovative Solar Generating Station Leading the way in sustainability and innovative green technologies, Stanford celebrated the opening of the Stanford Solar Generating Station in Kern County, Calif. The station will provide more than 50 percent of Stanford’s electricity. DECEMBER 5, 2016 Leading the way in sustainability and innovative [..]

Parkinson’s Disease Linked to Microbiome

December 6, 2016 Scipreneur Private Limited 0

Parkinson’s Disease Linked to Microbiome By Lori Dajose (CALTECH News) Caltech scientists have discovered for the first time a functional link between bacteria in the intestines and Parkinson’s disease (PD). The researchers show that changes in the composition of gut bacterial populations—or possibly gut bacteria themselves—are actively contributing to and [..]

FDA Approves Nivolumab for Head and Neck Cancer

December 6, 2016 Scipreneur Private Limited 0

FDA Approves Nivolumab for Head and Neck Cancer By: NCI Staff December 5, 2016 The Food and Drug Administration (FDA) approved nivolumab (Opdivo®) on November 10 for the treatment of squamous cell cancer of the head and neck (SCCHN). Nivolumab is already approved for the treatment of several other cancers. [..]

New interim data demonstrate Sandoz proposed biosimilar rituximab has equivalent efficacy to reference product

December 6, 2016 Scipreneur Private Limited 0

New interim data demonstrate Sandoz proposed biosimilar rituximab has equivalent efficacy to reference product ASSIST-FL trial demonstrates equivalent safety, efficacy, pharmacokinetics and pharmacodynamics of Sandoz proposed biosimilar rituximab (GP2013) to the reference product[1] Interim data in over 600 adults show potential of GP2013 as an alternative rituximab[1] Sandoz proposed biosimilar [..]

Novartis data shows Treatment-free Remission rates are consistently above 50% regardless of reason for switch to Tasigna® from Glivec®

December 5, 2016 Scipreneur Private Limited 0

Novartis data shows Treatment-free Remission rates are consistently above 50% regardless of reason for switch to Tasigna® from Glivec® ENESTop post-hoc analysis provides further insights into Treatment-free Remission (TFR) among Ph+ CML switch patients[1] The Tasigna TFR trials, including ENESTop, demonstrate our continued commitment to the CML community By: Novertis [..]

Design your own custom drone

December 5, 2016 Scipreneur Private Limited 0

Design your own custom drone CSAIL system lets users design and fabricate drones with a wide range of shapes and structures. By: Adam Conner-Simons | CSAIL  (MIT NEWS) December 5, 2016 This fall’s new Federal Aviation Administration regulations have made drone flight easier than ever for both companies and consumers. But [..]

Novartis presents results from first global registration trial of CTL019 in pediatric and young adult patients with r/r B-ALL

December 5, 2016 Scipreneur Private Limited 0

Novartis presents results from first global registration trial of CTL019 in pediatric and young adult patients with r/r B-ALL 82% (41 of 50) of patients achieved complete remission or complete remission with incomplete blood count recovery in interim analysis of Novartis study (ELIANA) ELIANA, the first global CAR T cell [..]

Genentech’s Gazyva Helped People With Previously Untreated Follicular Lymphoma Live Significantly Longer without their Disease Worsening Compared to Rituxan

December 5, 2016 Scipreneur Private Limited 0

Genentech’s Gazyva Helped People With Previously Untreated Follicular Lymphoma Live Significantly Longer without their Disease Worsening Compared to Rituxan First Phase III study to show superior progression-free survival compared to Rituxan-based standard of care treatment for most common slow-growing form of non-Hodgkin’s lymphom Results will be presented during the Plenary [..]

IoT Evolution Expo

December 4, 2016 Scipreneur Private Limited 0

IoT Evolution Expo January 7-10, 2017, Fort Lauderdale, FL  The IoT Evolution Expo, organized by the IoT Evolution Expo will take place from 7th January to 10th January 2017 in Fort Lauderdale, United States Of America. The conference will cover areas like Machine-to-machine (M2M) communications, Microprocessor/microcontroller choices, IoT for Automotive, [..]

Startup World Cup 2017

December 4, 2016 Scipreneur Private Limited 0

Startup World Cup 2017 Startup World Cup is a global conference and competition that brings together the top startups, VCs, entrepreneurs and world-class tech CEOs. They are partnering with some of world’s largest conferences and tech events to host 16 regional startup competitions for North & South America, Europe, Asia, [..]

A Hydrogel That Helps Stop Uncontrolled Bleeding

December 4, 2016 Scipreneur Private Limited 0

A Hydrogel That Helps Stop Uncontrolled Bleeding Works in patients on blood thinners or with bleeding disorders By Benjamin Boettner, Wyss Institute Communications Small blood clots called emboli are mostly known for traveling through the vasculature before they lodge and obstruct vessels, impeding blood and oxygen supply to organs such [..]

Novartis SEG101 (crizanlizumab, formerly SelG1) significantly reduces frequency of sickle cell pain crises in Phase II study

December 3, 2016 Scipreneur Private Limited 0

Novartis SEG101 (crizanlizumab, formerly SelG1) significantly reduces frequency of sickle cell pain crises in Phase II study SEG101 reduced annual rate of sickle cell-related pain crises (SCPC) by 45.3% compared to placebo in patients with or without hydroxyurea therapy   SEG101 is a potential new disease-modifying, preventive treatment option for [..]

New Phase 2 Results Show Investigational Compound Glasdegib Improved Overall Survival in Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

December 3, 2016 Scipreneur Private Limited 0

  New Phase 2 Results Show Investigational Compound Glasdegib Improved Overall Survival in Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome Data on First Smoothened Inhibitor to Show Clinical Benefit in This Patient Population to be Presented During Oral Session at 2016 ASH Annual Meeting December 3, 2016    Today, Pfizer [..]

Computer Learns to Recognize Sounds by Watching Video

December 3, 2016 Scipreneur Private Limited 0

Computer Learns to Recognize Sounds by Watching Video Machine-learning system doesn’t require costly hand-annotated data. Larry Hardesty | MIT News Office December 3, 2016     In recent years, computers have gotten remarkably good at recognizing speech and images: Think of the dictation software on most cellphones, or the algorithms [..]